Rebound activation of 5-HT neurons following SSRI discontinuation

Haddad P. Newer antidepressants and the discontinuation syndrome. J Clin Psychiatry. 1997;58:17–21.

CAS  PubMed  Google Scholar 

Horowitz M, Taylor D. How do we determine whether antidepressants are useful or not? Lancet Psychiatry. 2019;6:888.

Article  PubMed  Google Scholar 

Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav. 2019;97:111–21.

Article  PubMed  Google Scholar 

Price JS, Waller PC, Wood SM, MacKay AV. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol. 1996;42:757–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gastaldon C, Schoretsanitis G, Arzenton E, Raschi E, Papola D, Ostuzzi G, et al. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database. Drug Safety. 2022;45:1539–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom. 2015;84:72–81.

Article  PubMed  Google Scholar 

Bosker FJ, Tanke MA, Jongsma ME, Cremers TI, Jagtman E, Pietersen CY, et al. Biochemical and behavioral effects of long-term citalopram administration and discontinuation in rats: role of serotonin synthesis. Neurochem Int. 2010;57:948–57.

Article  CAS  PubMed  Google Scholar 

Collins HM, Pinacho R, Ozdemir D, Bannerman DM, Sharp T. Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice. J Psychopharmacol. 2022;36:794–805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Handley SL, McBlane JW. Serotonin mechanisms in animal models of anxiety. Braz J Med Biol Res. 1993;26:1–13.

CAS  PubMed  Google Scholar 

Sharp T. Molecular and cellular mechanisms of antidepressant action. Curr Top Behav Neurosci. 2013;14:309–25.

Article  CAS  PubMed  Google Scholar 

Blier P, Tremblay P. Physiologic mechanisms underlying the antidepressant discontinuation syndrome. J Clin Psychiatry. 2006;67:8–13.

CAS  PubMed  Google Scholar 

Harvey BH, Slabbert FN. New insights on the antidepressant discontinuation syndrome. Hum Psychopharmacol. 2014;29:503–16.

Article  CAS  PubMed  Google Scholar 

Renoir T. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved. Front Pharmacol. 2013;4:45.

Article  PubMed  PubMed Central  Google Scholar 

Trouvin JH, Gardier AM, Chanut E, Pages N, Jacquot C. Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat. Life Sci. 1993;52:PL187–92.

Article  CAS  PubMed  Google Scholar 

Stenfors C, Ross SB. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life Sci. 2002;71:2867–80.

Article  CAS  PubMed  Google Scholar 

Fuller RW, Perry KW, Molloy BB. Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci. 1974;15:1161–71.

Article  CAS  PubMed  Google Scholar 

Ogren SO, Ross SB, Hall H, Holm AC, Renyi AL. The pharmacology of zimelidine: a 5-HT selective reuptake inhibitor. Acta Psychiatr Scand Suppl. 1981;290:127–51.

Article  CAS  PubMed  Google Scholar 

Barton CL, Hutson PH. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Synapse. 1999;31:13–19.

Article  CAS  PubMed  Google Scholar 

Kuhn DM, Wolf WA, Youdim MB. Serotonin neurochemistry revisited: A new look at some old axioms. Neurochem Int. 1986;8:141–54.

Article  CAS  PubMed  Google Scholar 

Sharp T, Bramwell SR, Clark D, Grahame-Smith DG. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J Neurochem. 1989;53:234–40.

Article  CAS  PubMed  Google Scholar 

Rogawski MA. Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr. 2005;5:225–30.

Article  PubMed  PubMed Central  Google Scholar 

Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020;395:1938–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lerner A, Klein M. Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. Brain Commun. 2019;1:fcz025.

Article  PubMed  PubMed Central  Google Scholar 

Warlick H, Leon L, Patel R, Filoramo S, Knipe R, Joubran E, et al. Application of gabapentinoids and novel compounds for the treatment of benzodiazepine dependence: the glutamatergic model. Mol Biol Rep. 2023;50:1765–84.

Article  PubMed  Google Scholar 

Antoniadou I, Kouskou M, Arsiwala T, Singh N, Vasudevan SR, Fowler T, et al. Ebselen has lithium-like effects on central 5-HT(2A) receptor function. Br J Pharmacol. 2018;175:2599–610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franklin, KBJ, Paxinos, G. The Mouse Brain in Stereotaxic Coordinates. Academic Press, (1997).

Radford-Smith DE, Probert F, Burnet P, Anthony DC. Modifying the maternal microbiota alters the gut-brain metabolome and prevents emotional dysfunction in the adult offspring of obese dams. Proc Natl Acad Sci USA. 2022;119:e2108581119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gorlova A, Ortega G, Waider J, Bazhenova N, Veniaminova E, Proshin A, et al. Stress-induced aggression in heterozygous TPH2 mutant mice is associated with alterations in serotonin turnover and expression of 5-HT6 and AMPA subunit 2A receptors. J Affect Disord. 2020;272:440–51.

Article  CAS  PubMed  Google Scholar 

Guilloux JP, David DJ, Xia L, Nguyen HT, Rainer Q, Guiard BP, et al. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology. 2011;61:478–88.

Article  CAS  PubMed  Google Scholar 

Couch Y, Xie Q, Lundberg L, Sharp T, Anthony DC. A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice. PLoS One. 2015;10:e0130643.

Article  PubMed  PubMed Central  Google Scholar 

Vogelgesang S, Niebert S, Renner U, Möbius W, Hülsmann S, Manzke T, et al. Analysis of the Serotonergic System in a Mouse Model of Rett Syndrome Reveals Unusual Upregulation of Serotonin Receptor 5b. Front Mol Neurosci. 2017;10:61.

Article  PubMed  PubMed Central  Google Scholar 

Yu Z, Lin D, Zhong Y, Luo B, Liu S, Fei E, et al. Transmembrane protein 108 involves in adult neurogenesis in the hippocampal dentate gyrus. Cell Biosci. 2019;9:9.

Article  PubMed  PubMed Central  Google Scholar 

Sharp T, Boothman L, Raley J, Quérée P. Important messages in the ‘post’: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci. 2007;28:629–36.

Article  CAS  PubMed  Google Scholar 

Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, et al. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses. Eur J Pharmacol. 1998;347:41–9.

Article  CAS  PubMed  Google Scholar 

Ohmura Y, Tsutsui-Kimura I, Sasamori H, Nebuka M, Nishitani N, Tanaka KF, et al. Different roles of distinct serotonergic pathways in anxiety-like behavior, antidepressant-like, and anti-impulsive effects. Neuropharmacology. 2020;167:107703.

Article  CAS  PubMed  Google Scholar 

Kreilgaard M, Smith DG, Brennum LT, Sánchez C. Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol. 2008;155:276–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bourin M, Chue P, Guillon Y. Paroxetine: a review. CNS Drug Rev. 2001;7:25–47.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif